These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 314303)

  • 1. The separation of Willebrand factor from factor VIII-related antigen.
    Barrow ES; Reisner HM; Graham JB
    Br J Haematol; 1979 Jul; 42(3):455-68. PubMed ID: 314303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological evidence that human factor VIII is composed of two linked moieties.
    Koutts J; Lavergne JM; Meyer D
    Br J Haematol; 1977 Nov; 37(3):415-28. PubMed ID: 341960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time course of changes in in vitro platelet function and plasma von willebrand factor activity (VIIIR:WF) and factor VIII-related antigen (VIIIR:Ag) in the diabetic rat.
    Winocour PD; Lopes-Virella M; Laimins M; Colwell JA
    J Lab Clin Med; 1983 Nov; 102(5):795-804. PubMed ID: 6415193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of insulin treatment in streptozocin-induced diabetic rats on in vitro platelet function and plasma von Willebrand factor activity and factor VIII-related antigen.
    Winocour PD; Lopes-Virella M; Laimins M; Colwell JA
    J Lab Clin Med; 1985 Sep; 106(3):319-25. PubMed ID: 3928783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor VIII procoagulant activity, factor VIII related antigen and von Willebrand factor in newborn cord blood.
    Fukui H; Takase T; Ikari H; Murakami Y; Okubo Y; Nakamura K
    Br J Haematol; 1979 Aug; 42(4):637-46. PubMed ID: 314304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial incidence of precipitating antibodies in von Willebrand's disease: a study of four cases.
    Ruggeri ZM; Ciavarella N; Mannucci PM; Molinari A; Dammacco F; Lavergne JM; Meyer D
    J Lab Clin Med; 1979 Jul; 94(1):60-75. PubMed ID: 112210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity of von Willebrand's disease: study of 40 Iranian cases.
    Shoa'i I; Lavergne JM; Ardaillou N; Obert B; Ala F; Meyer D
    Br J Haematol; 1977 Sep; 37(1):67-83. PubMed ID: 303911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of plasma fibronectin (cold-insoluble globulin) and components of the factor VIII complex after heparin-induced precipitation of plasma.
    Amrani DL; Mosesson MW; Hoyer LW
    Blood; 1982 Mar; 59(3):657-63. PubMed ID: 6800421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of a simple visual assay of Willebrand factor for diagnosis and carrier identification.
    Reisner HM; Katz HJ; Goldin LR; Barrow ES; Graham JB
    Br J Haematol; 1978 Oct; 40(2):339-50. PubMed ID: 309339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gel filtration patterns of factor VIII coagulant antigen and factor VIII related antigen in normal and von Willebrand's disease.
    Chediak J; Peake I; Bloom A
    Thromb Haemost; 1983 Aug; 50(2):509-12. PubMed ID: 6415844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor VIII (procoagulant activity VIII:C, and antigen VIII:CAg, related antigen VIIIR:Ag and ristocetin cofactor VIIIR:Cof) in intensive care patients with clinically suspected disseminated intravascular coagulation (DIC).
    Tran TH; Lämmle B; Duckert F
    Am J Clin Pathol; 1984 Nov; 82(5):565-72. PubMed ID: 6437209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Factor VIII complex activities in acute leukemia].
    Pniejnia-Olszyński W; Lopaciuk S
    Acta Haematol Pol; 1980; 11(4):239-47. PubMed ID: 6794320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two distinct forms of Factor VIII coagulant protein in human plasma. Cleavage by thrombin, and differences in coagulant activity and association with von Willebrand factor.
    Weinstein MJ; Chute LE
    J Clin Invest; 1984 Feb; 73(2):307-16. PubMed ID: 6421875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo interactions of autoantibodies to factor VIII with the factor VIII complex.
    Allain JP; Croissant MP; Lerolle D; Houbouyan L; Zuzel M; Frommel D
    Thromb Haemost; 1982 Oct; 48(2):142-5. PubMed ID: 6817443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification of factor VIII complex properties in patients with liver disease.
    Maisonneuve P; Sultan Y
    J Clin Pathol; 1977 Mar; 30(3):221-7. PubMed ID: 300380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evaluation of factor VIII antigen by means of a simple slide test.
    Casonato A; Fabris F; Vicariotto M; Girolami A
    Am J Clin Pathol; 1985 Jul; 84(1):107-11. PubMed ID: 3925753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Destruction of ristocetin cofactor by coagulation at 4 degrees C.
    Lloyd JV; Tunbridge LJ; Rodgers SE; Hondow JA; Russell WJ
    Thromb Res; 1985 Mar; 37(6):659-68. PubMed ID: 3922085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity of sugar composition of factor VIII/von Willebrand factor in von Willebrand's disease: analysis by crossed affinoimmunoelectrophoresis using lectin (ricinus communis agglutinin-120).
    Mikami S; Ueda M; Yasui M; Takahashi Y; Nishino M; Fukui H
    Thromb Haemost; 1983 Apr; 49(2):87-90. PubMed ID: 6408753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of fibronectin in factor VIII/von Willebrand factor cryoprecipitation.
    Mazurier C; Samor B; Deromeuf C; Goudemand M
    Thromb Res; 1985 Mar; 37(6):651-8. PubMed ID: 3922084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneous abnormalities in the multimeric structure, antigenic properties, and plasma-platelet content of factor VIII/von Willebrand factor in subtypes of classic (type I) and variant (type IIA) von Willebrand's disease.
    Weiss HJ; Pietu G; Rabinowitz R; Girma JP; Rogers J; Meyer D
    J Lab Clin Med; 1983 Mar; 101(3):411-25. PubMed ID: 6186757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.